Life Technologies Corp (LIFE): Today's Featured Health Care Loser
Life Technologies (LIFE) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 1.4%. By the end of trading, Life Technologies fell 65 cents (-1.4%) to $45.64 on heavy volume. Throughout the day, 2.7 million shares of Life Technologies exchanged hands as compared to its average daily volume of 1.7 million shares. The stock ranged in price between $45.25-$47 after having opened the day at $46.93 as compared to the previous trading day's close of $46.29. Other company's within the Health Care sector that declined today were: Idera Pharmaceuticals (IDRA), down 20.3%, NeurogesX (NGSX), down 10.8%, Chemocentryx (CCXI), down 8.5%, and Anthera Pharmaceuticals (ANTH), down 7.5%. Life Technologies Corporation operates as a global life sciences company. Life Technologies has a market cap of $8.2 billion and is part of the health services industry. The company has a P/E ratio of 22.4, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 19% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Life Technologies a buy, no analysts rate it a sell, and six rate it a hold. TheStreet Ratings rates Life Technologies as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.
- You can view the full Life Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Latest Headlines about LIFE
-
The Deal: Thermo Fisher's Purchase of Life Technologies Runs Through China
12:53PM 05/08/13
-
'Mad Money' Lightning Round: Staying Away From Sandstorm Gold
06:00AM 04/30/13
-
Cramer's 'Mad Money' Recap: Dazed and Confused Markets
08:20PM 04/29/13
-
S&P Drops Most in 5 Months as Boston Explosion Heightens Market Concerns
07:15PM 04/15/13
-
Thermo Fisher Jumps on $13.6B Life Tech Deal
10:38AM 04/15/13
-
Dish Offers to Buy Sprint for $25.5 Billion: Ahead of the Ticker
09:51AM 04/15/13
-
Stock Futures Signal Declines as China Grows Less Than Forecast
08:26AM 04/15/13
Latest from TheStreet Wire
-
Axis Capital Holdings Ltd (AXS): Today's Featured Insurance Laggard
05:01PM 05/17/13
-
Validus Holdings Inc. (VR): Today's Featured Financial Laggard
05:01PM 05/17/13
-
Cavium Inc (CAVM): Today's Featured Electronics Laggard
05:01PM 05/17/13
-
Smithfield Foods Inc. (SFD): Today's Featured Consumer Goods Laggard
05:01PM 05/17/13
-
Autodesk Inc. (ADSK): Today's Featured Computer Software & Services Laggard
05:01PM 05/17/13
-
Goldcorp Inc. (GG): Today's Featured Basic Materials Laggard
05:01PM 05/17/13
-
Finisar Corporation (FNSR): Today's Featured Technology Laggard
05:01PM 05/17/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
